The UK Office of Life Sciences (OLS), a joint unit between the Department of Health and Social Care and Department for Business, Energy & Industrial Strategy (BEIS), has published its bulletin providing information for industry on preparation if the UK leaves the EU without a deal.
The bulletin points to various resources that Government hopes will prepare companies for Brexit. This includes a £10 million Business Readiness Fund announced by BEIS.
Also mentioned in the bulletin is the supply of medicines in the event of a ‘no deal’ Brexit:
“DHSC, in consultation with the Devolved Administrations (DAs), has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medical products to the whole of the UK and its Crown Dependencies in the event of a ‘no deal’ EU exit.”
In addition, the bulletin outlines the Government position on the Medicines and Healthcare products Regulatory Agency (MHRA) taking over functions and responsibility from the European Medicines Agency (EMA) in the event of a ‘no deal’ Brexit.
Find out more about the impact of Brexit on the life sciences industry on MAP Online.